Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine (42 Days) for Mucosal Leishmaniasis
NCT00373568Phase 2Completed
- Sponsor
- The A.B. Foundation for Medical Research
- Start
- Apr 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine in mucosal leishmaniasis (ML), sponsored by The A.B. Foundation for Medical Research. Started Apr 2005; status: completed.
02
Drugs
miltefosine
03
Conditions
mucosal leishmaniasis (ML)
Beyond the preview
Go deeper on NCT00373568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373568.